IceCure Medical, an Israeli company developing a minimally invasive medical device for treating tumors, recently announced that it will start offering its technology, called cryoablation, in Israel in upcoming weeks.
The company’s device is an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor and does not require hospitalization, leaves minimal to no scarring, and has a short recovery time. Destroyed tumor cells are then reabsorbed in the body over time.
The treatment, which is approved in the US and the European Union, will be available in Israel to women suffering from fibroadenomas, benign breast tumors usually found in women under 30, and for patients with malignant kidney tumors.
Article excerpts from calcalisttech.com
Gene transfer to the heart is no longer a script for science fiction.
Dr. Yael Graif of the Allergy and Immunology Clinic at Israel’s Rabin Medical Center’s Pulmonary Institute recently led a study examining the link between asthma and migraines.
A new study shows that breastfeeding for at least three months may reduce the risk of and even prevent Attention Deficit-Hyperactivity Disorder (ADHD).